US FDA Resumes China, India Inspections In Bid To Keep Drug Approvals On Schedule
Agency’s struggle to meet user fee commitments despite travel restrictions expected to worsen as pandemic continues into 2021.
You may also be interested in...
The House Appropriations Committee also does not want the agency to become too dependent on alternative inspection tools.
Foreign facility visits may take longer to reach usual levels because of the ongoing coronavirus outbreaks in other countries.
Agency inspectors worked in the country for about a month before the coronavirus infection surge forced another halt.